Scope
Reference
WT2025-07
Description
Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 30/11/2028.
Contract 1. WT2025-07 - SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection
Supplier
Contract value
- £4,638,166.35 excluding VAT
- £5,565,799.62 including VAT
Above the relevant threshold
Earliest date the contract will be signed
28 November 2025
Contract dates (estimated)
- 1 December 2025 to 30 November 2028
- 3 years
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Other information
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Direct award
Direct award justification
Single supplier - intellectual property or exclusive rights
Items were part of - 5749446 - Medicinal Products and Pharma Funded Homecare Services tender - No Bids
Supplier
NOVARTIS PHARMACEUTICALS UK LIMITED
- Companies House: 00119006
- Public Procurement Organisation Number: PJTX-5182-QVLR
2nd Floor, The Westworks Building White City Place
London
W12 7FQ
United Kingdom
Email: commercial.pricing@novartis.com
Website: https://www.novartis.com/uk-en/
Region: UKI33 - Kensington & Chelsea and Hammersmith & Fulham
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Contract 1. WT2025-07 - SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection
Contracting authority
Western Health & Social Care Trust
- Public Procurement Organisation Number: PTVW-2397-PWCT
Altnagelvin Area Hospital, Glenshane Road
Londonderry
BT47 6SB
United Kingdom
Region: UKN0A - Derry City and Strabane
Organisation type: Public authority - central government
Devolved regulations that apply: Northern Ireland